A comparative histologic analysis of tissue-engineered bone using platelet-rich plasma and platelet-enriched fibrin glue

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 102, Issue 2, 2006, Pages 175-179

  Zhu, Shi Jiang ^a   Choi, Byung Ho ^b   Jung, Jae Hyung ^c   Lee, Seoung Ho ^d   Huh, Jin Young ^c   You, Tae Min ^c   Lee, Hyun Jung ^c   Li, Jingxu ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c Yonsei University   (South Korea)

^d Ewha Womans University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; FIBRIN GLUE; GROWTH PROMOTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; BONE DEVELOPMENT; COMPARATIVE STUDY; DRUG EFFECT; FISCHER 344 RAT; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; METHODOLOGY; MOUSE; NONPARAMETRIC TEST; NUDE MOUSE; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE; TISSUE ENGINEERING;

ANIMALS; BLOOD PLATELETS; BONE MORPHOGENETIC PROTEINS; FIBRIN TISSUE ADHESIVE; GROWTH SUBSTANCES; INJECTIONS, SUBCUTANEOUS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, NUDE; OSTEOGENESIS; RATS; RATS, INBRED F344; STATISTICS, NONPARAMETRIC; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA;

EID: 33746225399     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2005.08.034     Document Type: Article

References (23)

1. Noshi T., Yoshikawa T., Dohi Y., et al. Recombinant human bone morphogenetic protein-2 potentiates the in vivo osteogenic ability of marrow/hydroxyapatite composites. Artif Organs 25 (2001) 201-208
2. Shimakura Y., Yamzaki Y., and Uchinuma E. Experimental study on bone formation potential of cryopreserved human bone marrow mesenchymal cell/hydroxyapatite complex in the presence of recombinant human bone morphogenetic protein-2. J Craniofac Surg 14 (2003) 108-116
3. Mankani M.H., Kuznetsov S.A., Fowler B., Kingman A., and Robey P.G. In vivo bone formation by human bone marrow stromal cells. effect of carrier particle size and shape. Biotechnol Bioeng 72 (2001) 96-101
4. Park D.J., Choi B.H., Zhu S.J., Huh J.Y., Kim B.Y., and Lee S.H. Injectable bone using chitosan-alginate gel/mesenchymal stem cells/BMP-2 composites. J Cranio-Maxillofac Surg 33 (2005) 50-54
5. Yamada Y., Ueda M., Naiki T., Takahashi M., Hata K., and Nagasaka T. Autogenous injectable bone for regeneration with dog mesenchymal stem cells (dMSCs) and platelet-rich plasma (PRP) tissue engineered bone regeneration. Tissue Eng 10 (2004) 955-964
6. Yamada Y., Ueda M., Naiki T., and Nagasaka T. Tissue-engineered injectable bone regeneration for osseointegrated dental implants. Clin Oral Impl Res 15 (2004) 589-597
7. Ito K., Yamada Y., Nagasaka T., Baba S., and Ueda M. Osteogenic potential of injectable tissue-engineered bone. a comparison among autogenous bone, bone substitute (Bio-oss), platelet-rich plasma, and tissue-engineered bone with respect to their mechanical properties and histological findings. J Biomed Mater Res 73A (2005) 63-72
8. Sanchez A.R., Sheridan P.J., and Kupp L.I. Is platelet-rich plasma the perfect enhancement factor? A current review. Int J Oral Maxillofac Implants 18 (2003) 93-103
9. Ganio C., Tenewitz F.E., Wilson R.C., and Maules B.G. The treatment of chronic nonhealing wounds using autologous platelet-derived growth factors. J Foot Ankle Surg 32 (1993) 263-268
10. Okuda K., Kawase T., Momose M., et al. Platelet-rich plasma contains high levels of platelet-derived growth factor and transforming growth factor-ß and modulates the proliferation of periodontally related cells in vitro. J Periodontol 74 (2003) 849-857
11. Thorn J.J., Sørensen H., Weis-Fogh U., and Andersen M. Autologous fibrin glue with growth factors in reconstructive maxillofacial surgery. Int J Oral Maxillofac Surg 33 (2004) 95-100
12. Maniatopoulos C., Sodek J., and Mekcher A.H. Bone formation in vitro by stromal cells obtained from marrow of young adults. Cell Tissue Res 254 (1988) 317-330
13. Dennis J.E., Haynesworth S.E., Young R.G., and Caplan A.I. Osteogenesis in marrow-derived mesenchymal stem cells/porous ceramic composites transplanted subcutaneously. effect fibronectin and laminin on cell retention and rate of osteogenesis expression. Cell Transplant 1 (1992) 23-32
14. Ueda M., Yamada Y., Ozawa R., and Okazaki Y. A clinical report of injectable tissue-engineered bone applied for alveolar augmentation with simultaneous implant placement. Int J Periodont Restor Dent 25 (2005) 129-137
15. Harris D.M., Siedentop K.H., Ham K.R., and Sanchez B. Autologous fibrin tissue adhesive biodegration and systemic effects. Laryngoscope 97 (1987) 1141-1144
16. Schmitt J.M., Hwang K., Winn S.R., and Hollinger J.O. Bone morphogenetic proteins. an update on basic biology and clinical relevance. J Orthop Res 17 (1999) 269-278
17. Hollinger J.O., and Leong K. Poly(a-hydroxy acids). carriers for bone morphogenetic proteins. Biomaterials 17 (1996) 187-194
18. Vehof J.W., Mahmood J., and Takita H. Ectopic bone formation in titanium mesh loaded with bone morphogenetic protein and coated with calcium phosphate. Plast Reconstr Surg 108 (2001) 434-443
19. Young J.Z., and Medawar P.B. Fibrin suture of peripheral nerves. Lancet 1 (1940) 126-130
20. Miyazono K., and Takaku F. Platelet-derived growth factors. Blood Rev 3 (1989) 269-276
21. Pierce G.F., Mustoe T.A., Altrock B.W., Deuel T.F., and Thomason A. Role of platelet-derived growth factor in wound healing. J Cell Biochem 45 (1991) 319-326
22. Whitman D.H., Berry R.L., and Green D.M. Platelet gel. an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 55 (1997) 1294-1299
23. Lynch S.E., Colvin R.B., and Antoniades H.N. Growth factors in wound healing. J Clin Invest 84 (1989) 640-646